Related Experiment Video
Updated: Jun 12, 2026

Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
Self-Assembling Imidazolium Nanoaggregates Trigger a Unique Dynamin-Dependent Cell Death via Cytoplasmic
Sayari Dewan1, Himanshu Sonker1, Kajal Chaudhary1
1Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.
Abstract:
The identification of alternative cell death pathways is key to developing therapies for apoptosis-resistant cancers. We investigated cell death induced by delocalized lipophilic cation (DLC) nanoaggregates in A549 lung carcinoma cells. These DLCs trigger a dynamin-dependent, nonapoptotic pathway involving cytoplasmic vesicle accumulation and mitochondrial dysfunction. Leveraging the mitochondria-targeting ability of lipophilic cations, we designed and synthesized fluorescent mitochondrion-toxic molecules with potent cytotoxicity against A549, MDA-MB-231, and MCF-7 cells. Dynamic light scattering revealed the nanoaggregate formation of the lead compound, L3, in the RPMI media. L3 inhibited metastasis and clonal expansion, induced vacuole formation post endocytosis, and impaired the mitochondrial function, disrupting ATP levels. This led to mitochondrial permeability transition pore (MPTP) opening and oxidative imbalance via glutathione perturbation. L3 demonstrated strong antitumor activity in vitro and in vivo, showing high potential for treating apoptosis-resistant cancers.
Insights
Researchers explored novel cell death pathways for apoptosis-resistant cancers. They developed delocalized lipophilic cation (DLC) nanoaggregates that induce nonapoptotic cell death, showing potential for cancer therapy.
Area of Science:
- Biochemistry
- Cell Biology
- Nanomedicine
Background:
- Apoptosis-resistant cancers pose a significant therapeutic challenge.
- Identifying alternative cell death mechanisms is crucial for novel cancer treatments.
Purpose of the Study:
- To investigate cell death induced by delocalized lipophilic cation (DLC) nanoaggregates in lung carcinoma cells.
- To design and synthesize novel mitochondrion-targeting molecules for cancer therapy.
Main Methods:
- Utilized dynamin-dependent pathways for cell death induction.
- Synthesized fluorescent mitochondrion-toxic molecules.
- Assessed cytotoxicity, nanoaggregate formation, metastasis inhibition, and mitochondrial function disruption.
Main Results:
- DLCs induced a nonapoptotic cell death pathway with cytoplasmic vesicle accumulation and mitochondrial dysfunction.
- The lead compound, L3, formed nanoaggregates and exhibited potent cytotoxicity against multiple cancer cell lines.
- L3 inhibited metastasis, clonal expansion, and disrupted mitochondrial ATP levels, leading to MPTP opening and oxidative imbalance.
Conclusions:
- L3 demonstrated significant antitumor activity both in vitro and in vivo.
- The developed mitochondrion-toxic molecules show high potential for treating apoptosis-resistant cancers.
More Related Videos
Related Concept Videos
Pinching-off of Coated Vesicles
Cancer Cell Migration through Invadopodia
The Extrinsic Apoptotic Pathway

